|
Volumn 32, Issue 3, 2001, Pages 211-216
|
Impact of a pediatric asthma clinical pathway on hospital cost and length of stay
|
Author keywords
Asthma; Children; Clinical pathway; Economics; Health care; Hospital costs; Outcome assessment; Pediatric asthma
|
Indexed keywords
BRONCHODILATING AGENT;
CORTICOSTEROID;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
CHILD;
CLINICAL PATHWAY;
CLINICAL PRACTICE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG UTILIZATION;
FOLLOW UP;
HOSPITAL ADMISSION;
HOSPITAL COST;
HOSPITAL DISCHARGE;
HUMAN;
LABORATORY TEST;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
OUTCOMES RESEARCH;
OXYGEN SATURATION;
PEAK EXPIRATORY FLOW;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RECURRENCE RISK;
THORAX RADIOGRAPHY;
ADOLESCENT;
ASTHMA;
CHILD;
CHILD, PRESCHOOL;
CRITICAL PATHWAYS;
FEMALE;
HOSPITAL COSTS;
HUMANS;
INFANT;
LENGTH OF STAY;
MALE;
PEDIATRICS;
PRACTICE GUIDELINES;
RECURRENCE;
RETROSPECTIVE STUDIES;
SPECIALTIES, MEDICAL;
|
EID: 0034867424
PISSN: 87556863
EISSN: None
Source Type: Journal
DOI: 10.1002/ppul.1110 Document Type: Article |
Times cited : (76)
|
References (13)
|